Frequency of Specimen Rejection and Associated Factors at St., Addis Ababa, Ethiopia

dc.contributor.advisorTsegaye Aster
dc.contributor.authorBenti Haile
dc.date.accessioned2018-06-29T07:26:17Z
dc.date.accessioned2023-11-06T08:57:34Z
dc.date.available2018-06-29T07:26:17Z
dc.date.available2023-11-06T08:57:34Z
dc.date.issued2014-07
dc.description.abstractBackground: In resource limited settings CD4+ T cell count (CD4 testing) facility is notavailable in peripheral areas and often either patients need to travel long distances or the samplesneed to be transported to the centers where the facility for CD4 testing is available. These resultscategory completed CD4 testing within 12 weeks of HIV testing. Among those not immediatelyeligible for ART (CD4 cells > 200/μl), only 31.5% completed CD4 testing within 12 weeks.Overall, of HIV+ patients who initiated CD4 testing, 61.65% did not complete it within 12weeks of diagnosis. Among the predicting factors, the higher the baseline CD4 cell count, thelower the odds of completing CD4 testing within 12 weeks (P<0.05). Conclusion: Majority of patients were already eligible for ART at the time of HIV diagnosiseven under the restrictive threshold of 200 CD4 cells/μl that prevailed at the time of the study.But most did not complete CD4 testing within 12 weeks of diagnosis. Proper linkage of patienttested positive at any testing center and provision of immediate baseline CD4 cell count hasindispensible role in reducing delayed treatment of patient with low CD4 cell count andmaintaining patient enrolled at ART clinicin delays in the completion of CD4 testing, and hence further delays occur in obtainingappropriate care and treatment. Objective: To estimate rates of completion of CD4+ T cell count within 12 weeks of testingpositive for human immunodeficiency virus (HIV) as well as predictors for completion at ARTclinics in Afar region of Northeast Ethiopia. Methods: The study was conducted in three most accessible selected Health centers with CD4sample referring and ART services found in Afar Region of Northeast Ethiopia. Monthly reportof HIV Positive patients was used to identify individuals with HIV positive results. Routine datawas used separately to calculate the number and proportion of patients passing through PICHT,VCT, PMTCT, TB clinic. Of the total 1299 positive individuals at each entry point, 931 werelinked to clinic patient card and ART data base. CD4 testing was considered complete once apatient had retrieved the test results. To determine the rate of CD4 testing completion, records ofpatient were reviewed. Predictors for completion were identified through multivariate logisticregression. SPSS version 16 was used for data cleaning and analysis. P values less than 0.05were taken as statistically significant. Result: Between September 1, 2007 and June, 2013, a total of 1299 patients consisted of492(37.88%), 387(29.79%), and 420(32.33%) at Gewane, Werer and Semera health centers,respectively were tested positive for HIV. Patients who initiated CD4 testing after they testedpositive for HIV and enrolled to ART clinic had a median CD4 cell count of 172/μl (interquartilerange, IQR: 88–261). Majority 326 (59.8% of 545) had a CD4 cell count ≤ 200/μl and werealready eligible for ART. The other 219 (40.2% of 545) had a CD4 cell count > 200/μl and werethus eligible for pre-ART medical care. en_US
dc.identifier.urihttp://etd.aau.edu.et/handle/123456789/4904
dc.language.isoenen_US
dc.publisherAddis Ababa Universityen_US
dc.subjectSpecimen Rejectionen_US
dc.titleFrequency of Specimen Rejection and Associated Factors at St., Addis Ababa, Ethiopiaen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Haile_Benti_2014_ETD.pdf
Size:
654.43 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: